11,230 results match your criteria: "Department of Clinical Oncology.[Affiliation]"

Background: This study aims to identify biomarkers for treatment response of atezolizumab plus bevacizumab (Atezo+Bev) in patients with hepatocellular carcinoma (HCC).

Methods: 96 patients who received Atezo+Bev or lenvatinib as a first-line systemic therapy were enrolled as the training group after propensity score matching (PSM), and 42 patients treated with Atezo+Bev were enrolled as the validation group. 17 serum cytokines were measured by Luminex multiplex assay at the start of treatment.

View Article and Find Full Text PDF

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a heterogeneous group of neoplasms with an increasing incidence in the last few decades. Despite therapeutic advances in the management of GEP-NENs, resistance to many of these treatments has made their management a great challenge. One of the most recent advances in oncologic therapy is targeting multiple receptors simultaneously and engaging immune cells in the tumor microenvironment through bispecific antibodies (BsAbs).

View Article and Find Full Text PDF

Introduction: Recurrent oral squamous cell carcinoma (SCC) poses significant challenges in treatment, requiring a multifaceted approach for effective management.

Case Presentation: We present the case of a 68-year-old patient with a history of keratonizing SCC of the mandibular gingiva, treated with surgical resection, adjuvant radiotherapy (RT) to a total dose of 60 Gy in 30 fractions and 6 cycles of concurrent chemotherapy. After 6 years of follow-up, the patient experienced a local late recurrence in clinical stage rT4N0M0 requiring palliative chemotherapy (6 cycles of PF regimen).

View Article and Find Full Text PDF

Magnetic resonance (MR)-guided radiation therapy (RT) is enhancing head and neck cancer (HNC) treatment through superior soft tissue contrast and longitudinal imaging capabilities. However, manual tumor segmentation remains a significant challenge, spurring interest in artificial intelligence (AI)-driven automation. To accelerate innovation in this field, we present the Head and Neck Tumor Segmentation for MR-Guided Applications (HNTS-MRG) 2024 Challenge, a satellite event of the 27th International Conference on Medical Image Computing and Computer Assisted Intervention.

View Article and Find Full Text PDF

Objectives: We aim to investigate the time toxicity of patients with gastroenteropancreatic neuroendocrine tumours treated with Lutetium-177 Dotatate in a single institution.

Design: This is a retrospective cohort study.

Methods: All patients with gastroenteropancreatic neuroendocrine tumours treated with Lutetium-177 Dotatate at the Alexander Fleming Institute were included.

View Article and Find Full Text PDF

Next-generation immunotherapy: igniting new hope for lung cancer.

Ther Adv Med Oncol

December 2024

State Key Laboratory of Translational Oncology, Department of Clinical Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong.

Adoption of immunotherapy has completely transformed the treatment landscape of cancer. Patients with advanced cancer treated with immunotherapy may benefit from durable tumor response and long-term survival. The most widely used immunotherapy in solid tumors is anti-programmed-death (ligand) protein (PD-(L)1), which is now an integral part of non-small cell lung cancer (NSCLC) treatment irrespective of histological cell types and tumor stage.

View Article and Find Full Text PDF

Long non-coding RNA (lncRNA) LINC01116 is crucial in promoting cell proliferation, invasion and migration in solid tumours, including lung adenocarcinoma (LUAD). LINC01116 acts as a competing endogenous RNAs (ceRNA) that binds competitively to microRNAs and plays a critical role in tumour migration and invasion. However, other mechanisms of action besides the ceRNA theory have been rarely reported and remain to be elucidated further.

View Article and Find Full Text PDF

BackgroundWith global aging, especially in Asia, preventing pneumonia among seniors is vital. The necessity of introducing pneumococcal vaccines among the elderly has been highlighted but there is a paucity of community-based real-world evidence on their effect. Sera Town in Hiroshima Prefecture, a super-aged community, launched a distinctive pneumococcal vaccination support project for elderly residents and conducted a 5-year follow-up survey.

View Article and Find Full Text PDF

Background: Medical cannabis (MC) has gained traction in oncology for managing cancer-related symptoms, but its integration faces challenges due to limited evidence, inconsistent guidelines, and varied legal frameworks.

Methods: The TASMAN study aimed to assess the knowledge, attitudes, and practices of oncologists and palliative care providers globally regarding MC use in cancer care. A survey of healthcare providers from diverse regions and income levels was conducted.

View Article and Find Full Text PDF

Post-acute sequelae of COVID-19 in cancer patients: Two cohorts in UK and Hong Kong.

Cancer Med

December 2024

Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Background: Limited research exists on the risks and spectrum of complications in post-acute phase of COVID-19 in cancer patients. This study aimed to evaluate the post-acute effects of COVID-19 on different types of morbidities among cancer patients across two regions with different healthcare systems and dominant variants of COVID-19.

Materials And Methods: Cancer patients with COVID-19 from the UK Biobank (UKB, n = 2230; March 16, 2020 to May 31, 2021; pre-Omicron-variants dominant) and electronic medical records in Hong Kong (HK cohort, n = 22,335; April 1, 2020 to October 31, 2022; Omicron-variant dominant) were included.

View Article and Find Full Text PDF

Introduction: In recent years, pain has been recognized as a primary factor significantly diminishing the quality of life in cancer patients. Recent data have prompted the establishment and increased application of non-pharmacological interventions in pain management, such as acupuncture.

Objectives: This review assesses literature from 2018 to 2023 on the impact of acupuncture on pain management and quality of life in cancer patients, with a particular focus on reducing pain intensity.

View Article and Find Full Text PDF

Aims: Cancer staging is routinely done in a multidisciplinary team meeting (MDM). There is however no established quality assurance (QA) for MDM-recorded cancer staging. Conversely, radiotherapy peer review is a recommended QA process.

View Article and Find Full Text PDF

Time to escalate quality assurance in small-cell lung cancer radiotherapy trials.

Lancet Respir Med

December 2024

Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer is predicted to rise significantly, with 35 million new cases expected by 2050, mainly impacting low- and middle-income countries, particularly in the SAARC region.
  • There is a research investment and output gap in SAARC countries compared to high-income nations, leaving a lack of local studies and clinical trials in crucial areas like targeted therapy and immunotherapy.
  • Addressing the challenges of healthcare access, cultural and economic barriers, and limited funding in SAARC countries requires collaboration, improved research infrastructure, and local studies to develop practical and affordable cancer treatments.
View Article and Find Full Text PDF
Article Synopsis
  • - The South Asian region faces a critical shortage of oncology professionals due to inadequate education and training programs, impacting the quality of cancer care.
  • - Challenges for oncology workers include lack of trained personnel, poor healthcare infrastructure, and limited educational resources.
  • - The paper suggests both short-term strategies to enhance training and long-term goals to create self-sufficient cancer care systems through regional collaboration and innovative education.
View Article and Find Full Text PDF
Article Synopsis
  • Cancer care in SAARC countries faces major challenges like poor infrastructure, lack of skilled professionals, and economic issues, leading to delayed diagnoses and worse health outcomes.
  • There are significant disparities in healthcare systems across the region, with some countries providing free public services while others rely heavily on out-of-pocket payments, creating financial inequities for cancer patients.
  • To improve cancer care, coordinated efforts are needed, including better infrastructure, expanded health insurance, and national cancer control programs, along with regional collaboration to ensure equitable access and advance health goals.
View Article and Find Full Text PDF
Article Synopsis
  • * In 2022, cancer accounted for about 9.3% of global cases and 12% of deaths in this region, with major cancers including lung, head and neck, gastrointestinal, cervical, and breast cancers.
  • * The text emphasizes the need for regional collaboration to create an effective cancer control plan, stressing the importance of strong political commitment to tackle the growing cancer crisis and align with Sustainable Development Goals for 2030.
View Article and Find Full Text PDF

Objective: The aim of this special report is to describe the 6th edition of "The Guidelines for the Management of Pulmonary Nodules Detected by Low-Dose CT Lung Cancer Screening ".

Methods: Since the 5th edition six years ago, a review of the literature and consideration of consistency with new evidence led to the revision of the 6th edition.

Results: The main revisions in the 6th edition can be summarized as follows: 1) addition of the section "Recommendations for Low-Dose CT Lung Cancer Screening in Japan"; 2) change in the recommended solid component diameter, and follow-up interval for nodules with a total mean diameter of less than 15 mm and a solid component diameter of less than 8 mm; 3) replacement of the recommended case images; and 4) introduction of the criteria of the Lung Cancer CT Screening Certification Organization.

View Article and Find Full Text PDF

Unveiling KLHL23 as a key immune regulator in hepatocellular carcinoma through integrated analysis.

Aging (Albany NY)

December 2024

Shenzhen Key Laboratory for Drug Addiction and Medication Safety, Department of Ultrasound, Institute of Ultrasonic Medicine, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China China.

Article Synopsis
  • - The study investigates the role of KLHL23, a member of the Kelch protein superfamily, in cancer by analyzing data from various cancer types in terms of patient survival and immune response.
  • - Multi-omics methods revealed that KLHL23 expression levels are linked to survival rates in specific cancers, like hepatocellular carcinoma and low-grade glioma, as well as the behavior of immune cells and chemotherapy effectiveness.
  • - Reduced levels of KLHL23 are associated with heightened immune activity and a better response to chemotherapy, indicating its potential as a valuable biomarker for cancer prognosis and treatment.
View Article and Find Full Text PDF

Up to one in five early breast cancer patients develop chronic upper limb lymphedema after breast cancer treatments. This treatment complication is irreversible and can significantly impact the quality of life of breast cancer survivors. The model of prospective surveillance and early intervention has emerged as a potential strategy to prevent the development of this debilitating treatment-related complication.

View Article and Find Full Text PDF

Inflammatory myofibroblastic tumour is a rare tumour. We present an atypical case of Inflammatory myofibroblastic tumour which was trachea in location, histocyte rich and ROS1 rearranged. The patient presented with upper airway obstruction, which was an asthma mimic.

View Article and Find Full Text PDF

Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer.

Int J Clin Oncol

December 2024

Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.

Background: Financial toxicity impacts the treatment choices, daily life, and health-related quality of life (HRQoL) of cancer patients. We investigated future variations in financial toxicity and HRQoL of patients with gynecologic cancer, evaluated using the COmprehensive Score for financial Toxicity (COST) questionnaire.

Methods: This multicenter study enrolled patients with gynecologic cancer incurring co-payments for anti-cancer drug treatment for over 2 months.

View Article and Find Full Text PDF

Purpose: To identify the prevalence and predictive factors of body image dissatisfaction among Chinese adolescent and young adult (AYA) survivors of sarcoma and to evaluate its associations with behavioral outcomes.

Methods: In total, 116 AYA survivors (response rate: 88%; 48.3% female; mean age 28.

View Article and Find Full Text PDF